... platform. The Company has pioneered the clinical application of human amniotic membrane and its role in stem cell research. The Company's first product, AmnioGrafta , is the only tissue graft designated by the FDA as homologous for promoting ...
http://www.pehub.com/2013/08/22/ballast-point-ventures-river-cities-capital-funds-invest-tissuetech/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+pehub%2Fnews%2Fall+%28PEHub+News%29
http://www.pehub.com/2013/08/22/ballast-point-ventures-river-cities-capital-funds-invest-tissuetech/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+pehub%2Fnews%2Fall+%28PEHub+News%29
No comments:
Post a Comment